摘要
目的:观察黄芪注射液佐治小儿病毒性心肌炎的临床疗效。方法:将66例病毒性心肌炎住院患儿随机分为治疗组33例,对照组33例,对照组采用常规综合治疗,治疗组加用黄芪注射液静脉滴注,观察两组患儿的临床症状、心电图、心肌酶谱等指标变化。结果:治疗组总有效率为93.94%,对照组总有效率为72.73%,差异有统计学意义(P<0.05)。结论:黄芪注射液治疗病毒性心肌炎可提高疗效,无明显不良反应。
Objective： To observe clinical efficacy of Astragalus Injection as an auxiliary therapy in viral myocarditis in children.Methods： 66 patients hospitalized children with viral myocarditis were randomly divided into treatment group（33 cases） and control group（33 cases）,control group with conventional treatment,in treatment group were added by Astragalus Injection intravenous infusion,change of clinical symptoms,ECG,myocardial zymogram and other indicators of two groups were observed.Results： Total effective rate of treatment group was 93.94%,total effective rate of control group was 72.73%,the difference between two groups had statistical significance（P0.05）.Conclusion： Astragalus Injection for the treatment of viral mycocarditis can improve the efficacy and has no obvious adverse reactions.
出处
《中国医药导报》
CAS
2010年第36期48-49,共2页
China Medical Herald
关键词
黄芪注射液
病毒性心肌炎
儿童
Astragalus Injection
Viral myocarditis
Children
